Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The distal human intestine harbors trillions of microbes that allow us to extract calories from otherwise indigestible dietary polysaccharides. The products of polysaccharide fermentation include short-chain fatty acids that are ligands for Gpr41, a G protein-coupled receptor expressed by a subset of enteroendocrine cells in the gut epithelium. To examine the contribution of Gpr41 to energy balance, we compared Gpr41 −/− and Gpr41 +/+ mice that were either conventionally-raised with a complete gut microbiota or were reared germ-free and then cocolonized as young adults with two prominent members of the human distal gut microbial community: the saccharolytic bacterium, Bacteroides thetaiotaomicron and the methanogenic archaeon, Methanobrevibacter smithii . Both conventionally-raised and gnotobiotic Gpr41 −/− mice colonized with the model fermentative community are significantly leaner and weigh less than their WT (+/+) littermates, despite similar levels of chow consumption. These differences are not evident when germ-free WT and germ-free Gpr41 knockout animals are compared. Functional genomic, biochemical, and physiologic studies of germ-free and cocolonized Gpr41 −/− and +/+ littermates disclosed that Gpr41-deficiency is associated with reduced expression of PYY, an enteroendocrine cell-derived hormone that normally inhibits gut motility, increased intestinal transit rate, and reduced harvest of energy (short-chain fatty acids) from the diet. These results reveal that Gpr41 is a regulator of host energy balance through effects that are dependent upon the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Rodent-based studies also suggest that SCFAs may influence gut motility [57], suppress appetite (through enhanced incretin [glucagon-like peptide-1, GLP-1] release) and enhance insulin sensitivity [58].”
From The Health Benefits of Dietary Fibre (2020) · cites this paper as [57]
In the citing paper
“indigestible carbohydrates in the diet are fermented by the intestinal microbiota to produce short-chain fatty acids, which regulate immune function54, 55, intestinal hormone production, and lipogenesis56.”
From Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease (2014) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“In addition, colonization of adult GF mice, fed a standard polysacchariderich chow diet, with two organisms—Bacteroides thetaiotaomicron, a prominent saccharolytic bacterium in the normal distal human gut microbiota and an adept adaptive forager of polysaccharides (6), plus Methanobrevibacter smithii, a dominant metha…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Adult germ-free (GF) mice are leaner than their age- and gender-matched conventionally raised (CONV-R) counterparts who have acquired a microbiota beginning at birth (1).”
BackgroundSelf-citationTurnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915 · cited 13×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundInfluentialSelf-citationMechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615 · cited 1×
“Locomotor activity and body temperature were assessed for 5 d using a telemetry device (minimitter PDT-4000; Mini Mitter) beginning 7 d after implantation (20).”
MethodSelf-citationBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., & White, B. A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1817 · Cited by 1,711 · cited 1×
“Our proteome has a very limited repertoire of glycoside hydrolases needed to digest complex dietary plant polysaccharides: the microbiota synthesizes a large arsenal of these enzymes (2), and allows us to process complex dietary carbohydrates to short-chain fatty acids (SCFAs), principally acetate, propionate, and but…”
BackgroundLe Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
Cited by
Items 301–400 of 1,001
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Fogelson, K. A., Dorrestein, P. C., Zarrinpar, A., & Knight, R. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.022 · Cited by 177
“However, this effect is absent in germ-free GPR41 mice, 98 again suggesting a role for the microbiome in mediating its effect.”
Tong, M., Li, X., Wegener Parfrey, L., Roth, B., Ippoliti, A., Wei, B., Borneman, J., McGovern, D. P. B., Frank, D. N., Li, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080702 · Cited by 177
“Other short-chain fatty acid (SCFA) producing bacteria including Eubacterium, Roseburia, Faecalibacterium and Coprococcus were also observed in the blue FMC [67-69].”
BackgroundSingh, V., Chassaing, B., Zhang, L., San Yeoh, B., Xiao, X., Kumar, M., Baker, M. T., Cai, J., Walker, R., Borkowski, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.028 · Cited by 175
“SCFAs not only serve as a major fuel (i.e., butyrate) for the colonocytes but also are absorbed via enterohepatic circulation and contribute to hepatic lipogenesis (den Besten et al., 2013a; Samuel et al., 2008; Wolever et al., 1989).”
BackgroundThe Interplay Between Fiber and the Intestinal Microbiome in the Inflammatory Response
Kuo, S.-M. (2013) · Advances in Nutrition · doi:10.3945/an.112.003046 · Cited by 174
Kremmyda, L.-S., Tvrzicka, E., Stankova, B., & Zak, A. (2011) · Biomedical Papers · doi:10.5507/bp.2011.052 · Cited by 173
Holmes, Z. C., Villa, M. M., Durand, H. K., Jiang, S., Dallow, E. P., Petrone, B. L., Silverman, J. D., Lin, P.-H., & David, L. A. (2022) · Microbiome · doi:10.1186/s40168-022-01307-x · Cited by 171
“Augmenting these functions may explain the protective role of SCFAs in 63 diseases ranging from obesity to inflammatory bowel diseases (3, 10-20).”
BackgroundReview article: dietary fibre in the era of microbiome science
O’Grady, J., O’Connor, E. M., & Shanahan, F. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15129 · Cited by 172
“Peptide YY production via microbial and SCFA signalling also occurs in a GPR41 dependent fashion and has a role in delaying gut motility and prolonging nutrient absorptive capacity.(42) Further metabolic functions include”
BackgroundFree fatty acid receptors as therapeutic targets for the treatment of diabetes
Ichimura, A., Hasegawa, S., Kasubuchi, M., & Kimura, I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00236 · Cited by 170
“PYY and GLP-1 secretion was reduced in primary cultured endocrine cells derived from Ffar3 KO mice (Samuel et al., 2008; Tolhurst et al., 2012).”
BackgroundFree Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors
Offermanns, S. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135945 · Cited by 171
Liao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 168
Dietary Fiber and the Human Gut Microbiota: Application of Evidence Mapping Methodology
Sawicki, C., Livingston, K., Obin, M., Roberts, S., Chung, M., & McKeown, N. (2017) · Nutrients · doi:10.3390/nu9020125 · Cited by 169
“SCFAs, such as butyrate, acetate, and propionate produced by the fermentation of dietary fibers, may play a role in energy homeostasis, immune function, and host-microbe signaling [7,22,23], and prevention of diseases, such as bowel disease, colon cancer, and metabolic syndrome [20,24–26].”
BackgroundXiao, S., Liu, C., Chen, M., Zou, J., Zhang, Z., Cui, X., Jiang, S., Shang, E., Qian, D., & Duan, J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10174-w · Cited by 169
Role of free fatty acid receptors in the regulation of energy metabolism
Hara, T., Kashihara, D., Ichimura, A., Kimura, I., Tsujimoto, G., & Hirasawa, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.06.002 · Cited by 168
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
Mokhtari, Z., Gibson, D. L., & Hekmatdoost, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013151 · Cited by 166
“Binding to GPR41 is associated with upregulation of peptide YY (PYY) and glucagon-like peptide 1 [(GLP1), anorectic hormones] that have effects on appetite control; therefore, SCFAs are linked to food intake by activating these receptors (78, 79).”
BackgroundFrom microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology
Natarajan, N., & Pluznick, J. L. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2014 · Cited by 165
“Interest in SCFAs as microbe-to-host signals has steadily increased in recent years, as several studies linking gut microbes to host physiology have shown that SCFAs appear to be the “link” by which microbes communicate with the host (50, 54, 58, 62, 87, 91).”
BackgroundInfluentialToubal, A., Kiaf, B., Beaudoin, L., Cagninacci, L., Rhimi, M., Fruchet, B., da Silva, J., Corbett, A. J., Simoni, Y., Lantz, O., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17307-0 · Cited by 165
Impact of Intestinal Microbiota on Growth and Feed Efficiency in Pigs: A Review
Gardiner, G. E., Metzler-Zebeli, B. U., & Lawlor, P. G. (2020) · Microorganisms · doi:10.3390/microorganisms8121886 · Cited by 164
Gut microbiota–derived short-chain fatty acids and kidney diseases
Li, L., Ma, L., & Fu, P. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s150825 · Cited by 164
“48,51,52 ,53–55 In contrast, GLP-1 influences peripheral metabolic effects by stimulating insulin secretion and increasing glucose tolerance.”
BackgroundLactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet
Takemura, N., Okubo, T., & Sonoyama, K. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009377 · Cited by 163
Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance
Carvalho, B. M., & Abdalla Saad, M. J. (2013) · Mediators of Inflammation · doi:10.1155/2013/986734 · Cited by 163
“Thus, no proposed treatment attempting to induce the proliferation of certain bacterial phyla has been suggested until now.”
BackgroundScheepers, L. E. J. M., Penders, J., Mbakwa, C. A., Thijs, C., Mommers, M., & Arts, I. C. W. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.178 · Cited by 162
Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors
Falomir-Lockhart, L. J., Cavazzutti, G. F., Giménez, E., & Toscani, A. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00162 · Cited by 161
“FFAR3 enteroendocrine expression links signaling of short FAs from the microbiota with enteric hormone secretion (Samuel et al., 2008).”
BackgroundThe interaction between the gut Microbiota and herbal medicines
An, X., Bao, Q., Di, S., Zhao, Y., Zhao, S., Zhang, H., Lian, F., & Tong, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109252 · Cited by 162
Duca, F. A., Sakar, Y., Lepage, P., Devime, F., Langelier, B., Doré, J., & Covasa, M. (2014) · Diabetes · doi:10.2337/db13-1526 · Cited by 161
“Gut microbiota modulates expression of intestinal nutrientreceptors(7,11), and here we demonstrate that obesity-associated differences in GPRs were replicated in GF recipient mice, affecting the ability of EECs to sense and respond to intestinal nutrients.”
BackgroundInfluentialRetractedThe Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism
Yu, Y., Raka, F., & Adeli, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122227 · Cited by 160
Won, Y.-J., Lu, V. B., Puhl, H. L., & Ikeda, S. R. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3102-13.2013 · Cited by 157
“FFA3 and FFA2 are expressed in the intestine where SCFAs are produced (Karaki et al., 2008; Samuel et al., 2008; Tazoe et al., 2009) as well as at other sites involved with metabolism, including pancreatic islets, blood cells (monocytes and neutrophils), and white adipose tissue (Le Poul et al.”
BackgroundCodella, R., Luzi, L., & Terruzzi, I. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.11.016 · Cited by 158
Kim, Y., Keogh, J. B., & Clifton, P. M. (2017) · Nutrients · doi:10.3390/nu9111271 · Cited by 170
“SCFAs stimulate the expression of peptide YY via the G-protein-coupled receptors (Gpr41 and Gpr43) leading to the inhibition of gut motility and suppression of appetite [126,127].”
BackgroundGut-Muscle Axis Exists and May Affect Skeletal Muscle Adaptation to Training
Przewłócka, K., Folwarski, M., Kaźmierczak-Siedlecka, K., Skonieczna‐Żydecka, K., & Kaczor, J. J. (2020) · Nutrients · doi:10.3390/nu12051451 · Cited by 195
Bultman, S. J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2483 · Cited by 157
“GPR41 is intriguing because it mediates microbiota-induced effects on host metabolism including adiposity and the production of leptin and peptide YY (PYY) that regulate feeding behavior (35).”
Palau-Rodriguez, M., Tulipani, S., Isabel Queipo-Ortuño, M., Urpi-Sarda, M., Tinahones, F. J., & Andres-Lacueva, C. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01151 · Cited by 157
“…the intestinal motility and the transport of digestion products such as short-chain fatty acids, which are an energy source for colonocytes (Samuel et al., 2008); (iii) the regulation of gastrointestinal peptide hormone secretion, by suppressing the secretion of the lipoprotein lipase…”
BackgroundFree Fatty Acid Receptors and Their Role in Regulation of Energy Metabolism
Hara, T., Kimura, I., Inoue, D., Ichimura, A., & Hirasawa, A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_13 · Cited by 173
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier
Rondinella, D., Raoul, P. C., Valeriani, E., Venturini, I., Cintoni, M., Severino, A., Galli, F. S., Mora, V., Mele, M. C., Cammarota, G., et al. (2025) · Nutrients · doi:10.3390/nu17050859 · Cited by 213
“SCFAs also modulate appetite and improve insulin sensitivity through the secretion of gut hormones such as glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and the binding G protein-coupled receptor (GPR41 and GPR43) [39,40].”
van Deuren, T., Blaak, E. E., & Canfora, E. E. (2022) · Obesity Reviews · doi:10.1111/obr.13498 · Cited by 180
“Experiments conducted in knockout GPR41 mice suggest the receptor to be involved in peptide YY (PYY) release, intestinal transit rate, and energy harvest from the diet.(124) GPR43 is pre-”
BackgroundHuart, J., Leenders, J., Taminiau, B., Descy, J., Saint‐Remy, A., Daube, G., Krzesinski, J.-M., Melin, P., Tullio, P. D., & Jouret, F. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12588 · Cited by 158
“Note that higher amounts of SCFAs in stools of hypertension patients may also be secondary to decreased intestinal absorption of SCFAs, as suggested by Samuel et al.(14,35) The definition of hypertension was not conventional in previous reports, which questions the validity of patient categorization and data interpret…”
BackgroundImpact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 171
“Several in vitro and in vivo preclinical studies have shown that SCFAs may modify colonic motor patterns by promoting the release of neuroendocrine modulators from the epithelium, such as GLP-1 and PYY from enteroendocrine L cells, and 5-HT from enterochromaffin [217,218].”
BackgroundLee, P., Yacyshyn, B. R., & Yacyshyn, M. B. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13561 · Cited by 151
“Mice deficient in GPR41 (FFAR3), a GPCR expressed on enteroendocrine cells, were leaner than WT mice.(87) Similarly, GPR43-deficient HFD-fed mice were leaner and had improved insulin sensitivity(88) when compared with WT mice.”
Importance of Nutrients and Nutrient Metabolism on Human Health.
Chen, Y., Michalak, M., & Agellon, L. B. (2018) · PubMed Central · Cited by 266
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 168
Guasch‐Ferré, M., Hu, F. B., Ruiz‐Canela, M., Bulló, M., Toledo, E., Wang, D. D., Corella, D., Gómez‐Gracia, E., Fiol, M., Estruch, R., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006524 · Cited by 151
Enteroendocrine cell types revisited
Engelstoft, M. S., Egerod, K. L., Lund, M. L., & Schwartz, T. W. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.018 · Cited by 170
Emerging concepts in intestinal immune control of obesity-related metabolic disease
Khan, S., Luck, H., Winer, S., & Winer, D. A. (2021) · Nature Communications · doi:10.1038/s41467-021-22727-7 · Cited by 149
Gut microbiota and host metabolism in liver cirrhosis
Usami, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11597 · Cited by 149
Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors
Pluznick, J. L. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.033 · Cited by 148
Pathophysiological role of host microbiota in the development of obesity
Kobyliak, N., Virchenko, O., & Falalyeyeva, T. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0166-9 · Cited by 149
A Gut Feeling for Obesity: 7TM Sensors on Enteroendocrine Cells
Engelstoft, M. S., Egerod, K. L., Holst, B., & Schwartz, T. W. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.004 · Cited by 162
“…secrete peptide hormones in response to sensation of food and gut microbiota products, can now be genetically tagged, isolated, cultured, and characterized for expression of the elusive chemosensors, as shown in publications in PNAS (Samuel et al., 2008) and in this issue (Reimann et al., 2008).”
BackgroundInfluentialBoleij, A., & Tjalsma, H. (2012) · Biological Reviews · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 146
Kellermayer, R., Dowd, S. E., Harris, R. A., Balasa, A., Schaible, T. D., Wolcott, R. D., Tatevian, N., Szigeti, R., Li, Z., Versalovic, J., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-172205 · Cited by 146
Microbiota‐gut‐brain axis as a regulator of reward processes
García‐Cabrerizo, R., Carbia, C., O´Riordan, K. J., Schellekens, H., & Cryan, J. F. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15284 · Cited by 144
“…consumption have also been observed in germ-free mice, associated with an increase in the expression of specific glucose transporters in the gut (Swartz et al., 2012), which may be responsible for regulating the release of gastrointestinal peptides (Hirasawa et al., 2005; Samuel et al., 2008).”
BackgroundRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
The homeostatic role of neuropeptide Yin immune function and its impact on mood and behaviour
Farzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145
“Apart from its effect to inhibit gastrointestinal motility as well as electrolyte and water secretion (Saria & Beubler 1985, Holzer et al. 1987, HolzerPetsche et al. 1991, Cox 2007a), NPY is of distinct relevance to immune function in the gastrointestinal mucosa (Bedoui et al. 2007, Wheway et al.…”
BackgroundZhao, L., Ni, Y., Su, M., Li, H., Dong, F., Chen, W., Wei, R., Zhang, L., Guiraud, S. P., Martin, F.-P., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00660 · Cited by 144
A longitudinal study of the diabetic skin and wound microbiome
Gardiner, M., Vicaretti, M., Sparks, J., Bansal, S., Bush, S., Liu, M., Darling, A., Harry, E., & Burke, C. M. (2017) · PeerJ · doi:10.7717/peerj.3543 · Cited by 144
“Dysbiosis of the human microbiome is increasingly recognised to play a role in 56 many diseases, through mechanisms such as altered intestinal barrier function (Kelly et al. 2015), 57 triggering or exacerbating inflammation (Strober 2013) and regulation of energy metabolism 58 (Samuel et al. 2008).”
BackgroundThe effects of gut microbiota on CNS function in humans
Tillisch, K. (2014) · Gut Microbes · doi:10.4161/gmic.29232 · Cited by 144
The Role of the Intestine in the Development of Hyperuricemia
Yin, H., Liu, N., & Chen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845684 · Cited by 176
A uroguanylin-GUCY2C endocrine axis regulates feeding in mice
Valentino, M. A., Lin, J. E., Snook, A. E., Li, P., Kim, G. W., Marszalowicz, G., Magee, M. S., Hyslop, T., Schulz, S., & Waldman, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57925 · Cited by 143
Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)
Sun, J., Chen, S., Zang, D., Sun, H., Sun, Y., & Chen, J. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5632 · Cited by 165
“By interacting with GPR43 and GPR41 receptors on the surface of intestinal endocrine L cells, butyrate promotes the secretion of glucagon‑like peptide‑1 and peptide tyrosine‑tyrosine, which are essential for main‑ taining energy balance (105,106) (Fig.”
BackgroundAbdollahi‐Roodsaz, S., Abramson, S. B., & Scher, J. U. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.68 · Cited by 150
Lee, W.-J., & Brey, P. T. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122333 · Cited by 140
Small talk: microbial metabolites involved in the signaling from microbiota to brain
Caspani, G., & Swann, J. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.08.001 · Cited by 138
Dietary Fiber: An Opportunity for a Global Control of Hyperlipidemia
Nie, Y., & Luo, F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5542342 · Cited by 161
“Studies also revealed that SCFAs could cause satiety via increased production of GLP-1 and PYY by stimulating FFARs and inhibit the rate-limiting enzyme of cholesterol HMGCoA reductase to inhibit cholesterol synthesis [131, 132].”
BackgroundHigher level of faecal SCFA in women correlates with metabolic syndrome risk factors
Teixeira, T. F. S., Grześkowiak, Ł., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., & Peluzio, M. C. G. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512002723 · Cited by 137
“Higher faecal concentrations of propionate and acetate induced by colonisation of germ-free mice with specific bacteria-producing SCFA resulted in higher weight and fat gain((20)).”
BackgroundInfluentialMiyamoto, J., Watanabe, K., Taira, S., Kasubuchi, M., Li, X., Irie, J., Itoh, H., & Kimura, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196579 · Cited by 160
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health
Ha, C. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16498 · Cited by 137
Antihypertensive Effects of Probiotics
Robles‐Vera, I., Toral, M., Romero, M., Jiménez, R., Sánchez, M., Pérez‐Vizcaíno, F., & Duarte, J. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0723-4 · Cited by 146
Mishra, S. P., Karunakar, P., Taraphder, S., & Yadav, H. (2020) · Biomedicines · doi:10.3390/biomedicines8060154 · Cited by 136
“FFAR2 expresses in hypothalamus [19], bone marrow [10,59], heart [68], liver [4,5,19], PBMC [35,53–56,69], stomach [19], pancreatic islet β-cells [25], lungs [40], epidermal fat pads [4,19], white adipose tissue (WAT) including perirenal, epidermal, and subcutaneous tissues [22,26], ileum and colon [4,19] particularly…”
BackgroundInfluentialAkkermansia muciniphila : is it the Holy Grail for ameliorating metabolic diseases?
Yan, J., Sheng, L., & Li, H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1984104 · Cited by 154
“Interestingly, GPR41 is involved in the microbiotaassociated adiposity process, as regularly raised Gpr41 mice are leaner than wild-type mice, whereas this difference is not observed under germfree (GF) conditions.(104) Activation of GPR41 and GPR43 induces intestinal L cells to produce peptide YY (PYY), glucagon-like…”
BackgroundKopczyńska, J., & Kowalczyk, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380476 · Cited by 164
Swartz, T. D., Duca, F. A., de Wouters, T., Sakar, Y., & Covasa, M. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511003412 · Cited by 135
“Previous work examining the effects of conventionalisation on metabolic, hormonal and morphological alterations in GF mice showed that conventionalisation reversed most, if not all, differences observed((5,28,40)).”
BackgroundInfluentialCardiovascular and antiobesity effects of resveratrol mediated through the gut microbiota
Bird, J. K., Raederstorff, D., Weber, P., & Steinert, R. E. (2017) · Advances in Nutrition · doi:10.3945/an.117.016568 · Cited by 136
Stringer, A. M., Al‐Dasooqi, N., Bowen, J. M., Tan, T. H., Radzuan, M., Logan, R. M., Mayo, B. J., Keefe, D. M. K., & Gibson, R. J. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1741-7 · Cited by 135
Targeting gut microbiota as a possible therapy for diabetes
He, C., Shan, Y., & Song, W. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.03.002 · Cited by 144
Chen, J., Li, Y., Tian, Y., Huang, C., Li, D., Zhong, Q., & Ma, X. (2015) · Current Protein & Peptide Science · doi:10.2174/1389203716666150630135720 · Cited by 134
Esteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
Effects of theabrownin on serum metabolites and gut microbiome in rats with a high-sugar diet
Yue, S., Zhao, D., Peng, C., Tan, C., Wang, Q., & Gong, J. (2019) · Food & Function · doi:10.1039/c9fo01334b · Cited by 137
Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions
Miyamoto, J., Ohue‐Kitano, R., Mukouyama, H., Nishida, A., Watanabe, K., Igarashi, M., Irie, J., Tsujimoto, G., Satoh‐Asahara, N., Itoh, H., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912573116 · Cited by 140
Short chain fatty acids: the messengers from down below
Mansuy‐Aubert, V., & Ravussin, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1197759 · Cited by 149
“, 2014), metabolic disorders (Samuel et al., 2008; Bellahcene et al., 2013; Tang et al., 2015), and in promoting sympathetic tone (Inoue et al.”
BackgroundVlieg, J. E. V. H., Veiga, P., Zhang, C., Derrien, M., & Zhao, L. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.12.004 · Cited by 147
Bellahcene, M., O'Dowd, J. F., Wargent, E. T., Zaibi, M. S., Hislop, D. C., Ngala, R. A., Smith, D. M., Cawthorne, M. A., Stocker, C. J., & Arch, J. R. S. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512003923 · Cited by 132
“Absence of GPR41 was associated with increased intestinal transit rate and reduced absorption of energy((13)).”
BackgroundResultInfluentialObesity and the gastrointestinal microbiota: a review of associations and mechanisms
Graham, C., Mullen, A., & Whelan, K. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv004 · Cited by 131
How functional foods play critical roles in human health
Pang, G., Xie, J., Chen, Q., & Zhi-he, H. (2012) · Food Science and Human Wellness · doi:10.1016/j.fshw.2012.10.001 · Cited by 150
Altitudinal variation of the gut microbiota in wild house mice
Suzuki, T. A., Martins, F. M., & Nachman, M. W. (2018) · Molecular Ecology · doi:10.1111/mec.14905 · Cited by 144
“Interestingly, SCFAs are not only an important energy source, but they also act as signalling molecules by travelling through the bloodstream and binding to SCFA receptors in various tissues (Samuel et al., 2008).”
BackgroundGut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment
Yang, F., Chen, H., Gao, Y., An, N., Li, X., Pan, X., Yang, X., Tian, L., Sun, J., Xiong, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110503 · Cited by 147
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 128
Mathur, R., Amichai, M., Chua, K. S., Mirocha, J., Barlow, G. M., & Pimentel, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3144 · Cited by 126
“Intestinal flora have been implicated in many mechanisms that may contribute to weight gain, including enhanced lipopolysaccharide production leading to insulin resistance (5), suppression of fasting-induced adipose factor (14), suppression of AMP-activated protein kinase-driven fatty acid oxidation in the liver (15),…”
BackgroundThe role of short-chain fatty acid on blood pressure regulation
Miyamoto, J., Kasubuchi, M., Nakajima, A., Irie, J., Itoh, H., & Kimura, I. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000246 · Cited by 136
“research has reported that SCFAs can influence metabolic [7] and inflammatory responses [8,9].”
BackgroundSykaras, A. G., Demenis, C., Case, R. M., McLaughlin, J. T., & Smith, C. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042373 · Cited by 126
“Previously, Samuel et al [20] showed that Gpr41/Ffar3 mRNA was”
BackgroundInfluentialEffects of the Artificial Sweetener Neotame on the Gut Microbiome and Fecal Metabolites in Mice
Chi, L., Bian, X., Gao, B., Tu, P., Lai, Y., Ru, H., & Lu, K. (2018) · Molecules · doi:10.3390/molecules23020367 · Cited by 124
Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats
Zhang, Q., Xiao, X., Li, M., Yu, M., Ping, F., Zheng, J., Wang, T., & Wang, X. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184735 · Cited by 124
The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1020-6 · Cited by 124
Anti-obesity effects of gut microbiota are associated with lactic acid bacteria
Tsai, Y.-T., Cheng, P.-C., & Pan, T. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5346-3 · Cited by 133
“Thus, Gpr41 might be a regulator of host energy balance through effects that are dependent on the gut microbiota and their metabolic capacity (Samuel et al. 2008), and gut microbiota may induce obesity in people consuming a high-fat diet (HFD) by both increasing the energy yield from the host's…”
BackgroundOleanolic Acid Targets the Gut–Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis
Xue, C., Li, Y., Lv, H., Zhang, L., Bi, C., Dong, N., Shan, A. S., & Wang, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02257 · Cited by 126
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 122
Renal and cardiovascular sensory receptors and blood pressure regulation
Pluznick, J. L. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00252.2013 · Cited by 119
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 129
“Fiberrich diets also promote a higher concentration of SCFA in the fecal contents, especially of butyrate, which has a beneficial effect on inflammation [162].”
BackgroundInfluentialMicrobiota in obesity: interactions with enteroendocrine, immune and central nervous systems
Mulders, R. J., de Git, K. C. G., Schéle, E., Dickson, S. L., Sanz, Y., & Adan, R. A. H. (2018) · Obesity Reviews · doi:10.1111/obr.12661 · Cited by 120
Defining an olfactory receptor function in airway smooth muscle cells
Aisenberg, W. H., Huang, J., Zhu, W., Rajkumar, P., Cruz, R., Santhanam, L., Natarajan, N., Yong, H. M., De Santiago, B., Oh, J. J., et al. (2016) · Scientific Reports · doi:10.1038/srep38231 · Cited by 118
Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome
Liauchonak, I., Qorri, B., Dawoud, F., Riat, Y., & Szewczuk, M. R. (2019) · Nutrients · doi:10.3390/nu11030644 · Cited by 144
“Here, specific substrates or metabolites can induce the preferential activation of these specific GPCRs [68,73].”
BackgroundGut Microbiota and the Pathogenesis of Insulin Resistance
Delzenne, N. M., & Cani, P. D. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0191-1 · Cited by 134
“[28] demonstrated that GPR41−/− mice colonized with fermentative microbes (B.”
BackgroundMetagenomics of the Human Body
Nelson, K. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3 · Cited by 121
Metadata
- Authors
- Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., & Gordon, J. I.
- Affiliations
- Washington University in St. Louis (US)
- The University of Texas Southwestern Medical Center (US)
- Japan Science and Technology Agency (JP)
- *Center for Genome Sciences and
- Howard Hughes Medical Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-10-28
- Volume
- 105
- Issue
- 43
- Pages
- 16767-16772
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2569967
- OpenAlex
- W2142336938
- Cited by
- 1,564
- References
- 23
- Citations by year
- 2026: 51 · 2025: 83 · 2024: 71 · 2023: 93 · 2022: 110 · 2021: 137 · 2020: 127 · 2019: 110 · 2018: 107 · 2017: 104 · 2016: 110 · 2015: 87 · 2014: 88 · 2013: 80 · 2012: 70
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK030292, DK-30292, DK 70977, R01DK070977, P30DK056341, R01DK030292)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- GPR41, gut microbiota, adiposity, short-chain fatty acids, energy balance, Bacteroides thetaiotaomicron, Methanobrevibacter smithii, peptide YY, enteroendocrine cells, intestinal transit, gnotobiotic mice, germ-free mice, polysaccharide fermentation, host-microbe interactions
- MeSH terms
- Animals, Bacteroides, Energy Metabolism, Germ-Free Life, Humans, Symbiosis, Mice, Knockout, Peptide YY, Methanobrevibacter, Gastrointestinal Tract, Receptors, G-Protein-Coupled, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.